Genotyping markers used for multi locus VNTR analysis with ompA (MLVA-ompA) and multi sequence typing (MST) retain stability in Chlamydia trachomatis by Clare Labiran et al.
ORIGINAL RESEARCH ARTICLE
published: 17 May 2012
doi: 10.3389/fcimb.2012.00068
Genotyping markers used for multi locus VNTR analysis
with ompA (MLVA-ompA) and multi sequence typing
(MST) retain stability in Chlamydia trachomatis
Clare Labiran1, Ian N. Clarke1, Lesley T. Cutcliffe1, Yibing Wang1, Rachel J. Skilton1,
Kenneth Persson2, Carina Bjartling3, Björn Herrmann4, Linus Christerson4 and Peter Marsh5*
1 Molecular Microbiology and Infection, School of Medicine, University of Southampton, Southampton, Hampshire, UK
2 Department of Clinical Microbiology, Malmö University Hospital, Malmö, Sweden
3 Department of Obstetrics and Gynaecology, Malmö University Hospital, Malmö, Sweden
4 Department of Medical Sciences, Section of Clinical Bacteriology, Uppsala University, Uppsala, Sweden
5 Health Protection Agency, Microbiology Services, Public Health Laboratory Southampton, Southampton General Hospital, Southampton, Hampshire, UK
Edited by:
Yasuko Rikihisa, Ohio State
University, USA
Reviewed by:
Ted Hackstadt, Rocky Mountain
Laboratories/NIAID/NIH, USA
Yajun Song, Beijing Institute of
Microbiology and Epidemiology,
China
João P. Gomes, National Institute of
Health, Portugal
*Correspondence:
Peter Marsh, Health Protection
Agency, Microbiology Services,
Public Health Laboratory
Southampton, Southampton
General Hospital, Tremona Road,
Southampton, SO16 6YD,
Hampshire, UK.
e-mail: peter.marsh@uhs.nhs.uk
We aimed to evaluate the stability of the Chlamydia trachomatis multi locus VNTR analysis
(MLVA-ompA) and multi sequence typing (MST) systems through multiple passages in
tissue culture. Firstly, we analyzed the stability of these markers through adaptation of
C. trachomatis to tissue culture and secondly, we examined the stability of a four-locus
MLVA-ompA and a five-locus MST system after multiple passages in tissue culture.
Marker sequences were monitored through successive chlamydial developmental cycles
to evaluate the stability of the individual DNA markers through many bacterial divisions
and this, in turn, informed us of the usefulness of using such typing systems for
short and long-term molecular epidemiology. Southampton genitourinary medicine (GUM)
clinic isolates from endocervical swabs collected from C. trachomatis positive women
were passaged through tissue culture. MLVA-ompA typing was applied to primary swab
samples and to the same samples after C. trachomatis had been passaged through cell
culture (eight passages). Sequence data from time-zero and passage-eight isolates were
aligned with reference sequences to determine the stability of the markers. The Swedish
new variant (nvCT) underwent 72 passages in cell culture and the markers of the two
schemes were similarly analyzed. Analysis of genetic markers of the MLVA-ompA typing
system before and after the isolates were introduced to tissue culture showed no change
in the dominant sequence. The nvCT that had been passaged 72 times over the duration
of a year also showed no variation in the dominant sequence for both the genotyping
schemes. MLVA-ompA and MST markers are stable upon adaptation of C. trachomatis
to tissue culture following isolation of strains from primary endocervical swab samples.
These markers remain stable throughout multiple rounds of cell-division in tissue culture,
concomitant with the incubation period and appearance of symptoms normally associated
with host-infection. Both genotyping schemes are, therefore, suitable for epidemiology of
C. trachomatis.
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INTRODUCTION
Chlamydia trachomatis, an intracellular bacterial pathogen is the
leading cause of sexually transmitted infections (STIs) worldwide.
The majority of diagnoses are in young people between the ages
of 15 and 24. C. trachomatis is currently divided into at least
15 serotypes. Genital infections are caused by the non-invasive
serotypes D to K and by the invasive lymphogranuloma venereum
(LGV) which infects the lymphatic system. If left untreated, which
is the case for up to 50% of men and 70% of women due to the
asymptomatic nature of this STI, a range of complications may
persist, although opportunistic screening and partner notification
detect a lot of asymptomatic cases. Individuals infected with LGV
can progress to develop proctitis, lymphadenopathy, and geni-
tal ulcerations, whereas disease outcome for individuals infected
with serotypes D to K range from infertility, ectopic pregnancy,
and pelvic inflammatory disease in women and epididymitis
in men.
The availability of whole genome sequences for C. trachoma-
tis has led to the development of several prototype genotyping
systems. Multilocus sequence typing (MLST) is one of these
typing techniques and it is usually based on 6–8 housekeep-
ing genes which are specifically chosen because they are not
under immune selection, and because of their role in cell sur-
vival. Therefore, MLST is useful when exploring long-term and
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global epidemiology and two such systems have been developed
for Chlamydiacae (Pannekoek et al., 2008; Dean et al., 2009).
To achieve a higher discriminating capacity a system based on
five non-housekeeping genes was created (Klint et al., 2007). It
is aimed for partner tracing and other short-term epidemiol-
ogy. This scheme was originally named as MLST, but the term
“MLST” strictly refers to the exclusive sequencing of small ampli-
cons from non-selectable housekeeping genes. In this paper the
designation of this scheme is reassigned to “multi sequence typ-
ing” (MST) as it encapsulates large and small amplicons, and
includes selectable non-housekeeping genes (Wang et al., 2011).
Pedersen et al. (2008) developed a high resolution typing scheme
which encompassed multi locus variable number tandem repeat
(VNTR) analysis and ompA (MLVA-ompA) (Pedersen et al., 2008,
2009; Wang et al., 2011). VNTR are defined as short regions of
nucleotide repeats or motifs. There are several MLVA schemes
practiced in bacteriology with various end-point measurement
methods including fluorescent amplicon size-discrimination and
sequence analysis of the VNTR loci (Pedersen et al., 2008; Schouls
et al., 2009). For C. trachomatis Pedersen et al. (2008) described
three VNTR regions; CT1335, CT1299, CT1291. Both the MST
system of Klint et al. (2007) and the Pedersen et al. (2008) MLVA-
ompA system provide a Simpson index of diversity between 0.94
and 0.96 as opposed to 0.64–0.83 when only ompA is typed
(Ikryannikova et al., 2010; Bom et al., 2011; Wang et al., 2011).
The guidelines outlined by the European Society of Clinical
Microbiology and Infectious Disease (ESCMID) states that a typ-
ing system should have a discriminatory power of no less than
0.95 in order to be “ideal” for studying epidemiology (van Belkum
et al., 2007). The MLVA DNA markers were selected for typing
because of their variability therefore, it is also particularly impor-
tant to assess the stability of thesemarkers when the study involves
sample collection by isolation of C. trachomatis in continuous cell
culture. In the study by Wang et al. (2011) a sub panel of sam-
ples could not be typed initially and were subsequently assigned a
MLVA-ompA type after culture (Wang et al., 2011).
Pedersen et al. (2008) have tested the stability of the three
markers and ompA in vivo in 24 patients with persistent or recur-
rent infection. Their results show that the markers are stable
between 70 and 394 days. However, this is very difficult to con-
trol as these patients were assessed under the assumption that it
was the same isolate the individual was infected with and also
that each of the 24 patients had not contracted chlamydia from a
different sex partner and could have, therefore, been re-infected.
The aim of our study was to evaluate the stability of the C. tra-
chomatis typing systems. The MLVA-ompA system was assessed
after multiple passages in the controlled conditions of cell culture.
By following potential changes through many developmental
cycles it was possible to establish the stability of the individ-
ual markers within a numerical framework of bacterial divisions
and this in turn informed us of the usefulness of using such
a typing system for short-term and longer-term molecular epi-
demiology. In this study we analyzed firstly, the stability of these
markers through adaptation of C. trachomatis to cell culture, in
doing so the initial genetic impact on the C. trachomatis genome
resulting from changing environmental conditions was analyzed.
Secondly, the stability of the VNTRmarkers with ompA as well as
the MST system (Klint et al., 2007) after multiple passages in cell
culture was evaluated.
METHODS
CELLS AND CULTURE OF C. trachomatis
McCoy cells were seeded into wells or flasks 24 h pre-infection.
Cells were grown overnight in Dulbecco’sModified Eaglemedium
(DMEM) containing 10% foetal calf serum (FCS) and then incu-
bated at 37◦C with 5% CO2. On the day of infection the medium
was removed and replaced with inoculum containing the C. tra-
chomatis isolates. This was then centrifuged at 754×g for 30min.
Subsequently the inoculum was replaced with DMEM contain-
ing cycloheximide (1µg/mL), gentamicin (20µg/mL), and van-
comycin (10µg/mL), and the cells incubated at 37◦C for 48 h.
After 48 h the inclusions were large enough and visible under
a light microscope so that the extent of infection could also be
determined visually to decide whether a larger surface area was
required for the next passage.
HARVESTING OF C. trachomatis ISOLATES FROMWELLS AND
FLASKS
Two days after infection tissue culture flasks were harvested, for
this a cell scraper was used to detach the cells from the plastic of
the flask. The sample was then centrifuged at 2851×g for 10min,
the supernatant was then discarded and the pellet resuspended in
1:10 cold phosphate buffered saline (PBS). The sample was then
added to glass beads and agitated for 1min to release the ele-
mentary bodies from the cell, centrifuged at 110×g for 5min to
remove any cell debris and the supernatant was then added to an
equal volume of 4 Sucrose Phosphate (4SP) and stored at −80◦C.
To harvest from wells the cells were scraped up into the medium
using a sterilized pipette tip, the 10min centrifugation step was
omitted as was the addition of PBS, instead the harvest was imme-
diately beaded and then the protocol for harvestingwas continued
as for harvesting from flasks.
Chlamydia trachomatis ISOLATES
In 2009, 157 endocervical swabs were collected over a six month
period fromwomen who had attended GUM clinics and GP surg-
eries in Southampton (Wang et al., 2011). The samples tested pos-
itive for C. trachomatis using a commercial real time PCR (Cobas
Taqman 48, Roche), performed in the Southampton Health
Protection Agency (HPA) Molecular Diagnostics Laboratory. To
test the stability of ompA and the VNTR markers (CT1335,
CT1299, and CT1291), seven of the archived isolates were chosen
(Table 1). Locations of these loci within the chlamydial genome
are shown in Table 2. The isolates were selected based on their
ompA type, so that all available ompA types could be included in
this study. The isolates were initially typed using the MLVA-ompA
typing system i.e., before inoculation of the primary sample into
tissue culture. All seven isolates were then taken through eight
serial passages in cell culture and were subsequently re-typed.
The stability of the Swedish new variant in cell culture was
also determined, an isolate from Malmo in Sweden was sent to
Southampton (Table 1), where it was passaged 72 times in cell
culture over the period of a year. The sample was obtained from
the urethra of a male patient who had contracted the new variant
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Table 1 | Isolates included in all studies and their sites of isolation, also included are the repeat sequences for the three VNTR loci, their
associated variant number, and the corresponding ompA NCBI database strain type for each isolate before culture.
ompA type (Determined by comparison Source Repeat sequence for each VNTR loci before culture Variant number
to NCBI database sequences)
CT1335 CT1299 CT1291
D/IC-CAL8 Cervix 13T7A 11C 8C 8, 5, 2
D/UW-3 Cervix 13T7A 11C 8C 8, 5, 2
E/Bour Cervix 13T7A 11C 8C 8, 5, 2
F/IC-CAL3 Cervix 13T7A 12C 8C 8, 6, 2
G/392 Cervix 10T8A 10CT3C 10C 3, 4ba, 4
Ia/870 Cervix 10T8A 11C 11C 3, 5, 5
K/UW-31 Cervix 10T8A 3C2T6C 10C 3, 9b, 4
E/Bour (SW2) Urethra 13T7A 14C 6C 8, 8, 1
aVNTR region modified in the Wang et al. paper.
bNew VNTR region found in Wang et al. (2011).
Table 2 | Location and putative function of the MLVA-ompA and MST
markers within the genome, also included is the strand (negative or
positive) in which the MST and ompA markers are located.
Marker (Scheme) Location and function
CT1335 (MLVA-ompA) Located at −44 to −66 of DNA topoisomerase
I/SWI domain fusion protein, Hypothetical protein
CT1299 (MLVA-ompA) Located in a non-coding region of the genome,
Hypothetical protein
CT1291 (MLVA-ompA) Located within the gene for the hypothetical
protein CT172.1
ompA (MLVA-ompA) Negative strand (−780,237: −778,702), Outer
membrane protein A
CT058 (MST) Negative strand (−68,693: −67,260),
Hypothetical protein
CT144 (MST) Positive strand (160,568: 161,678), Hypothetical
protein
CT172 (MST) Negative strand (−195,655: −195,016),
Hypothetical protein
hctB (MST) Positive strand (51,410: 52,205), DNA binding
protein
pbpB (MST) Positive strand (780,178: 784,392), Penicillin
binding protein B
The exact position (nucleotide number) within that strand is shown in brackets.
infection in Sweden in 2006. The Swedish new variant is a strain
which has a 377 bp deletion in the cryptic plasmid and 44 bp
duplication immediately upstream of CDS3, and is, therefore, a
mutable strain and most suitable for studying marker stability
(Ripa and Nilsson, 2006, 2007).
DNA EXTRACTION
DNAwas extracted from isolates that had been expanded to a level
of infection were there was enough to infect 100% of the cells in
a T75 tissue culture flask. DNA extraction was performed using
the Promega Wizard genomic DNA purification kit (Promega,
Southampton, UK) and was carried out according to manufac-
turer’s instructions.ThepresenceofDNAinthesamplewasverified
on an agarose DNA gel. The concentration of DNA present in
each isolate was determined using the Nanodrop 2000 (Thermo
Scientific, Delaware, USA). PCR was conducted with high fidelity
DNA polymerase, Phusion high fidelity DNA polymerase mas-
termix (New England Biolabs UK, Hitchin, UK), to ensure that
the sequence data obtained was of the best quality possible.
PCR AMPLIFICATION OF VNTR AND ompA SEQUENCES
MLVA-ompA analysis was carried out at Molecular Microbiology
and Infection, School of Medicine, University of Southampton.
VNTR and ompA sequences were amplified using PCR. OmpA
was amplified using primers P1F (Frost et al., 1991) and CT5
(Rodriguez et al., 1991), whilst the three VNTR regions were
amplified using primers outlined in Pedersen et al. (2008). PCR
reactions were carried out in 20µl volumes with the components
consisting of 10µl of Phusion high fidelity DNApolymerase mas-
termix (New England Biolabs UK, Hitchin, UK), 250 nM of the
forward and reverse primers and 2µl of DNA.
PCR conditions for the three VNTR sequences and ompAwere
as follows: 10 s at 98◦C, and 35 cycles of 2 s at 98◦C, 5 s at 59◦C,
and 10 s at 72◦C, followed by an elongation step for 1min at
72◦C. The temperature was then maintained at 10◦C. All strains
amplified had a CT1291 band that was 225 bp in size.
Purification of the PCR products was carried out usingWizard
SV gel and PCR clean-up system (Promega, Southampton, UK)
and this was carried out using the manufacturer’s instructions.
SEQUENCING OF MLVA-ompAMARKERS AND DETERMINATION
OF SEQUENCE STABILITY
Sequencing of PCR products were carried out by a commer-
cial company (Source Bioscience, Nottingham, UK). Sequencing
primers are described in Wang et al. (2011). OmpA sequences
were initially (before chlamydial passage) compared with
sequences available on the NCBI database using a BLAST search
and in doing so the ompA genotype was assigned to each iso-
late. The VNTR sequences were compared to the whole genome
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of D/UW-3/CX and thereafter assigned MLVA-types based on
the dominant sequence in the chromatograms according to
rules outlined in Pedersen et al. (2008). After the isolates were
taken through eight passages, the chlamydial ompA and VNTR
sequences were compared to sequence data received before the
isolates had been passaged.
The Swedish new variant, which was passaged 72 times, was
sequenced before passaging began and then every twelfth passage
up to 72 passages. These sequences were compared to the database
sequences and also to the sequence before the new variant had
been passaged.
SEQUENCING OF MST MARKERS AND DETERMINATION OF
SEQUENCE STABILITY
MST was carried out at the Section of Clinical Bacteriology,
Department of Medical Sciences, Uppsala University. The MST
scheme comprised five highly variable target regions and was
performed as previously described (Klint et al., 2007) except
that the pbpB region was amplified as two separate fragments
according to Jurstrand et al. (2010), and for sequencing of the
longer PCR products CT058 and pbpB internal sequence primers
were used in the scheme (Herrmann, personal communication).
DNA samples of chlamydia cell cultures passaged 72 times, sent
from Southampton to Uppsala as part of a batch of samples that
had been random coded so that sequence analysis was unbiased.
Sequences were compared to the sequence at each locus to all
known corresponding alleles available in the Uppsala University
C. trachomatis MLST database (http://mlstdb.bmc.uu.se), 178
sequence types comprising 183 allele variants in March 2011.
Sequences were thereafter compared to the original sequence of
the C. trachomatis strain in question, as obtained before starting
passage.
RESULTS
DETERMINATION OF THE STABILITY OF THE MLVA-ompA TYPING
SYSTEM
Seven endocervical C. trachomatis isolates from the Southampton
women’s study (Wang et al., 2011) were selected to analyse the
stability of the MLVA-ompA markers in cell culture. The crite-
ria for choosing these isolates were that they had to be capable
of at least two passages in cell culture and were, therefore, capa-
ble of being further passaged for this study. Secondly all isolates
selected formarker stability had to have different ompA genotypes
and they all had to have gone through the same number of pas-
sages in order for the data to be comparable. The isolates included
in this study comprised of seven ompA genotypes, which cor-
responded to the following NCBI database strains: D/IC-CAL8,
D/UW-3, E/Bour, K/UW-31, F/IC-CAL3, G/392, Ia/870 (Table 1).
For this study we wanted to include samples with shared MLVA
types (i.e., samples that had the same MLVA types but differ-
ent ompA types, these included local isolates which had identical
ompA sequences to the database sequence of D/IC-CAL8, D/UW-
3, and E/BOUR) (Table 1) so we could identify if there were any
differences in stability of the MLVA markers between different
ompA types.
The passaging of the isolate initially began with each isolate
being grown in a 24-well tray, then in a six-well tray and then into
flasks (T25 and T75). By the eighth passage all isolates were now
growing in a T75 flask where there were enough elementary bod-
ies available to infect all the cells. DNA was then extracted from
the elementary bodies and PCR reactions conducted for sequenc-
ing purposes. The chromatograms and sequence data received
were aligned to sequences obtained before the isolates were taken
through eight passages. Analysis of the alignments of the loci
showed that the markers were stable upon adaptation of the
chlamydia to cell culture as the sequence was unchanged from the
sequence before the sample had been cultured in mouse cells and
also that there is no change in the dominant sequence after eight
passages in cell culture.
PASSAGING OF THE SWEDISH NEW VARIANT AND DETERMINATION
OF THE STABILITY OF MLVA-ompAMARKERS IN CELL CULTURE
The Swedish new variant (serotype E with a 377 bp deletion in the
cryptic plasmid) isolated in Malmo, Sweden was taken through
a further 72 passages in cell culture (Figure 1) in Southampton,
UK, the process took one year to complete. The Swedish new vari-
ant was chosen because this isolate shows restricted cell tropism
(Unemo et al., 2010) and there is also greater possibility that
the MLVA-ompA markers are unstable in this “mutant” because
the strain was evidently mutable based on the plasmid sequence.
Sequences for markers from every twelfth passage were deter-
mined up to and including passage 72 (passage 0, 12, 24, 36, 48,
60, and 72). All the sequence data were aligned and there were no
changes seen in the MLVA-ompA profile at any passage that had
been sequenced.
DETERMINATIONOF THE STABILITY OF THE MST TYPING SYSTEM
IN CELL CULTURE
The stability of the C. trachomatis MST markers in cell culture
was also determined for the Swedish new variant which had been
passaged 72 times (Figure 1). For this study five MST regions
were analyzed these included; hctB, CT058, CT144, CT172, and
pbpB and were first described by Klint et al. (2007). The five
regions were sequenced and then aligned against corresponding
sequences for each marker that was available from the sequence
data of the Swedish new variant. The MST profile obtained was
21-19-1-2-1 and this was identical to the MST profile of the
Swedish new variant. This data shows that these fiveMSTmarkers
are also stable in tissue culture up to 72 passages.
DISCUSSION
There are currently five DNA typing systems published for geno-
typing C. trachomatis (Klint et al., 2007; Pannekoek et al., 2008;
Pedersen et al., 2008; Dean et al., 2009; Bom et al., 2011). These
typing systems use a number of regions within the C. trachomatis
genome to assign distinct labels to clinical specimens contain-
ing C. trachomatis based upon the order of nucleotides in the
sequence. The repeating sequences of VNTR loci build up due
to an increased error rate during DNA replication at these sites,
therefore, this raised error rate means that the stability of such
markers over multiple bacterial cell-divisions must be verified to
validate their use in epidemiology studies. To be useful for epi-
demiological studies the markers need to remain stable over the
duration of the study allowing the data collected to be comparable
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FIGURE 1 | Flow diagram showing the passage process of Sweden 2 and how the sample was processed to determine the stability of ompA and the
VNTR markers.
(van Belkum et al., 2007). Use of genomic regions which are
unstable may over represent the true distribution of bacterial
genotypes within a community. It is, therefore, imperative to
evaluate and understand the stability of the markers chosen for
epidemiological studies.
Utilization of the gene for the major outer membrane pro-
tein A (ompA) has, for a long time been one of the main typing
methods for distinguishing C. trachomatis. However, this method
actually provides little discrimination (Pedersen et al., 2008; Bom
et al., 2011) and masks the true phylogenetic relationships of the
strains (Harris et al., 2012). Three “MLST” schemes have also
been developed, two of which use seven housekeeping genes to
determine overall population structure of the whole chlamydiae
family (Pannekoek et al., 2008; Dean et al., 2009) and lastly a
scheme which is based on five highly variable genes, some of
which are under selection (which is designed to ensure high res-
olution) (Klint et al., 2007). Multi sequence typing (MST) best
describes the typing scheme designed by Klint et al. (2007) and
is the most discriminatory of the three “MLST” typing schemes
available for C. trachomatis. The fifth typing system available
for C. trachomatis is the MLVA-ompA scheme which uses three
variable regions within the genome to assign types to each iso-
late (Pedersen et al., 2008). These DNA markers were selected
for typing because of their variability, therefore, it is particularly
important to assess the stability of these markers in continuous
cell culture.
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The stability of the DNA markers used in the two typing
methods with the highest discriminatory power was assessed; the
Pedersen et al. MLVA-ompA typing system Pedersen et al. (2008)
and the Klint et al. (2007) MST typing system. Although ompA
had previously been shown to be stable through adaptation of
C. trachomatis to cell culture (Stothard et al., 1998), more recent
epidemiological studies suggest that within a single clone (e.g.,
nvCT—according to the MST scheme), minor single base sub-
stitutions occasionally appear (Herrmann et al., 2008); a similar
trend has been observed in LGV isolates (Christerson et al., 2010).
Our hypothesis was that adaptation of C. trachomatis to cell
culture conditions could affect marker stability, however, on the
contrary our data shows that the dominant MLVA sequences are
stable on adaptation of the C. trachomatis to cell culture. The
MLVA-ompA sequences were analyzed from DNA extracts taken
from primary swab samples (Wang et al., 2011) and after eight
passages in cell culture which is equivalent to approximately 80
divisions. To ensure our study covered a wide spread of C. tra-
chomatis types all the isolates chosen were selected on the basis
that they had differentMLVA-ompA types. Three isolates with dif-
ferent ompA types but the same MLVA profile were also included.
This could be indicative of recombination of the ompA gene.
Choosing isolates with different ompA types also acted as a ver-
ification that no contamination between strains had occurred
during passaging of the isolates. Although the in vivo conditions
in which C. trachomatis persists aremuchmore complex (involves
the immune system etc.) than that of the in vitro system that is
described here, the basis for taking the samples through eight pas-
sages to analyse the initial impact in cell culture was to mimic the
actual time it takes for symptoms to appear within an individ-
ual. Symptoms usually arise in individuals seven to twenty-one
days after infection occurs (Black, 1997), therefore, the isolates
were taken through twenty-four days from infection to harvest-
ing in cell culture to ensure the total time from being infected
to symptoms persisting in individuals was covered over the eight
passages.
A review by Bjorn-Arne Lindstedt states that it is imperative
that the VNTR loci selected for MLVA typing are thoroughly
checked before being applied to real-life situations, this includes
long-term passaging and re-typing to ensure the stability and the
reproducibility of each locus (Lindstedt, 2005). Pedersen et al.
(2008) previously assessed the markers in patients with recur-
rent or persistent C. trachomatis. Others have also evaluated the
MLVA system and found that some VNTR-markers may vary with
replication of single clones and cause difficulties in interpreta-
tion (Bom et al., 2011). Analysis of the stability in a controlled
environment by long term passaging of isolates was, therefore,
important thus the second part of our study was performed to
determine the stability of the MLVA-ompA and MST markers
(Klint et al., 2007) over seventy two passages using the Swedish
new variant. This isolate had already been subject to change in
vivo as illustrated by both a deletion and duplication within the
plasmid and may, therefore, be an unstable strain (or perhaps
a strain which has encountered an unknown selective pressure
causing the mutation), making this a useful isolate to test sta-
bility over a long duration. Three studies carried out in Sweden
have shown that the Swedish new variant is clonal. The first
study by Herrmann et al. (2008) typed 48 specimens from dif-
ferent regions in Sweden and three other countries. The study
not only showed that all isolates were genotype E according
to the ompA typing system but also that 96% of the isolates
had identical sequence types when typed using a highly dis-
criminatory MST method (Klint et al., 2007). Later studies by
Jurstrand et al. (2010) also showed that all specimens typed
(n = 41) had the same ompA type (genotype E) and the same
MST sequence types. The sequence type assigned to all sam-
ples was unique for the Swedish new variant. The third study
included nvCT cases from 2009 and although only 13 speci-
mens were analyzed it supports the stability of the MST target
regions over time (Klint et al., 2011). Although this evidence
suggested that the Swedish new variant is clonal and may be sta-
ble in vivo the transmission of the new variant from patient to
patient in these studies remains unknown and, therefore, it is
also unknown as to how many passages the new variant has been
through. Our in vitro studies were conducted under carefully con-
trolled conditions so the number of continuous passages were
defined.
In conclusion MLVA-ompA markers are stable through adap-
tation of C. trachomatis to growth in vitro and are also stable over
eight passages in cell culture. We have also cultured a mutable
isolate (the Swedish new variant of C. trachomatis) through 72
passages and showed that the MLVA-ompA and MST markers are
stable, however, complete definition of evolutionary adaptation
requires more isolates and extensive further passaging.
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